上市公司Propanc Biopharma宣布计划收购1亿美元以太坊
2025-09-02 13:10:43
生物制药公司Propanc Biopharma(纳斯达克股票代码:PPCB)今日(9月2日)宣布计划在未来12个月内收购价值1亿美元的以太坊。该公司表示，此举将增强其在加密货币投资、药物开发和资产收购等多方面的企业战略。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
